Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases. Our two platforms PIONEER and EDEN are utilizing the power of artificial intelligence, big data and supercomputing, to discover efficacious vaccines fast at almost no cost.

 

With some of the most talented bioinformaticians in our team, Evaxion is pioneering the field of immunoinformatics, working hard to bring novel, highly effective vaccines and antibodies to patients. By converting complex immunological data into computational algorithms, Evaxion is capable of programming the immune system to fight off a variety of diseases from cancers to hard-to-treat anti-microbial resistant infections.
EDEN Technology is an in silico antigen discovery platform that integrates big data, artificial intelligence and supercomputing. The key strength of EDEN is the ability to identify novel antigens, which cannot be identified with current technologies that elicit a highly and broadly protective immune response.
Evaxion is building a unique pipeline of highly efficacious prophylactic and therapeutic vaccines and antibodies against cancer and serious infectious diseases utilizing multiple best in class delivery technologies.

Contact Us

 

Submitting Form...The server encountered an error.Form received.

 

 

 

© Copyright 2015 Evaxion Biotech All rights reserved

Company

Vaccines and Antibodies

through artificial intelligence

^

^

FULLSCREEN VIDEO

 

 

 

© Copyright 2015 Evaxion Biotech All rights reserved